Literature DB >> 1958522

The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.

G J van Steenbrugge1, C J van Uffelen, J Bolt, F H Schröder.   

Abstract

The LNCaP-FGC (fast growing colony) cell line, a subline derived from the LNCaP cell line, shares all the main characteristics, including its androgen sensitivity, described for the parental line. A number of sublines originating from the FGC line were characterized with respect to their response to steroid-depleted medium and to the synthetic androgen R1881. The growth of FGC cells in DCC medium with 0.1 nM R1881 was stimulated 2-3-fold compared to growth in DCC medium only. FGC cells that were continuously grown in DCC medium did not die, but their growth rate was clearly slowed down, and the cells remained responsive to androgen. These cells, therefore, have the androgen-sensitive, rather than the androgen-dependent phenotype. As cells of the subline FGC-JB could not be maintained in DCC medium, these cells better represent the androgen-dependent cell type. In contrast to the FGC line, cells of the R line, grew equally well in medium with complete or DCC serum. Under none of these culture conditions, R cells could significantly be stimulated further with R1881. Further analysis of the LNCaP-FGC sublines should provide valuable information concerning the development of androgen resistance in human prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958522     DOI: 10.1016/0960-0760(91)90184-7

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  19 in total

1.  A hexane fraction of guava Leaves (Psidium guajava L.) induces anticancer activity by suppressing AKT/mammalian target of rapamycin/ribosomal p70 S6 kinase in human prostate cancer cells.

Authors:  Nae Hyung Ryu; Kyung-Ran Park; Sung-Moo Kim; Hyung-Mun Yun; Dongwoo Nam; Seok-Geun Lee; Hyeung-Jin Jang; Kyoo Seok Ahn; Sung-Hoon Kim; Bum Sang Shim; Seung-Hoon Choi; Ashik Mosaddik; Somi K Cho; Kwang Seok Ahn
Journal:  J Med Food       Date:  2012-01-26       Impact factor: 2.786

2.  LNCaP-OM, a new androgen-resistant prostate cancer subline.

Authors:  M Platica; R S Verma; M J Macera; O Platica
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

3.  Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation.

Authors:  Naoki Terada; Takumi Shiraishi; Yu Zeng; Koh-Meng Aw-Yong; Steven M Mooney; Zhi Liu; Sayuri Takahashi; Jun Luo; Shawn E Lupold; Prakash Kulkarni; Robert H Getzenberg
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

4.  Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.

Authors:  Sabine Schertl; Rolf W Hartmann; Christine Batzl-Hartmann; Thilo Spruss; Anton Maucher; Erwin von Angerer; Claus D Schiller; Martin R Schneider; Ronald Gust; Helmut Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-06       Impact factor: 4.553

5.  Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.

Authors:  Harryl D Martinez; Jordy J Hsiao; Rohini J Jasavala; Izumi V Hinkson; Jimmy K Eng; Michael E Wright
Journal:  Genes Cancer       Date:  2011-10

6.  Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

Authors:  Ilona N Holcomb; Janet M Young; Ilsa M Coleman; Keyan Salari; Douglas I Grove; Li Hsu; Lawrence D True; Martine P Roudier; Colm M Morrissey; Celestia S Higano; Peter S Nelson; Robert L Vessella; Barbara J Trask
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

7.  Characterization of a novel metastatic prostate cancer cell line of LNCaP origin.

Authors:  Mark A Castanares; Ben T Copeland; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Martin G Pomper; Shawn E Lupold; Catherine A Foss
Journal:  Prostate       Date:  2015-10-26       Impact factor: 4.104

8.  Neuroendocrine differentiation in human prostatic tumor models.

Authors:  M A Noordzij; W M van Weerden; C M de Ridder; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

9.  Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours.

Authors:  A Maucher; E von Angerer
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.

Authors:  Stéphane Terry; Pascale Maillé; Habiba Baaddi; Laurence Kheuang; Pascale Soyeux; Nathalie Nicolaiew; Jocelyn Ceraline; Virginie Firlej; Himisha Beltran; Yves Allory; Alexandre de la Taille; Francis Vacherot
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.